Cite
HARVARD Citation
George, S. et al. (n.d.). 501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial. European journal of cancer. pp. S102-S103. [Online].